Skip to main content

Stryker Secur-Fit & C-Taper LFit Linked To Design Defects

Stryker Secur-Fit & C-Taper LFit Linked To Design Defects

Stryker Secur-Fit & C-Taper LFit Linked To Design Defects

Introduction

In a recently filed product liability lawsuit, Stryker Howmedica Osteonics Corporation's hip implant component Secur-Fit femoral stem and C-Taper LFit femoral head were reported to be defectively designed and prone to corrosion. The lawsuit was filed by a couple on September 13 in the U.S. District Court for the District of Minnesota and indicates the implant is unreasonably risky.

The man underwent a left total hip arthroplasty in January 2011, and within a year of the surgery, he started developing pain and stiffness in the hip. After undergoing a revision surgery in October 2016, he suffered severe tissue necrosis and black sludge corrosion at the interface of the trunnion interface. The complaint filed states, the combination of a titanium alloy stem with a cobalt/chromium femoral head is known to cause fretting and corrosion, which was ignored by the manufacturer. Stryker faces hundreds of product liability lawsuits linked to complications of its LFit hip implant. Lawsuits associated with Stryker LFit components have been centralized for coordinated pretrial proceedings in the U.S. District Court for the District of Massachusetts overlooked by Judge Indira Talwani. The first bellwether trial has been scheduled to commence in September 2019.

Comments

In 2012 I was fitted with Secur-fit max 11 in one hip and Secjr-fit 12

-
Gerald Patterson

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!